BCL2 and acute myeloid leukemia: We further demonstrate that combinations of the VCP inhibitor CB-5083 with the antimetabolite cytarabine or the Bcl-2 inhibitor venetoclax act synergistically in killing different AML Interestingly, also another recently published study highlights a synergistic effect of VCP and Bcl-2 inhibition [15].